Logo image of SLND

SOUTHLAND HOLDINGS INC (SLND) Stock Fundamental Analysis

NYSEARCA:SLND - US84445C1009 - Common Stock

4.02 USD
-0.07 (-1.71%)
Last: 9/2/2025, 8:04:00 PM
4.02 USD
0 (0%)
After Hours: 9/2/2025, 8:04:00 PM
Fundamental Rating

1

SLND gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 53 industry peers in the Construction & Engineering industry. Both the profitability and financial health of SLND have multiple concerns. SLND does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year SLND has reported negative net income.
In the past year SLND has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: SLND reported negative net income in multiple years.
SLND had negative operating cash flow in 4 of the past 5 years.
SLND Yearly Net Income VS EBIT VS OCF VS FCFSLND Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

SLND has a Return On Assets of -6.22%. This is in the lower half of the industry: SLND underperforms 75.47% of its industry peers.
SLND has a Return On Equity of -48.80%. This is in the lower half of the industry: SLND underperforms 77.36% of its industry peers.
Industry RankSector Rank
ROA -6.22%
ROE -48.8%
ROIC N/A
ROA(3y)-1.66%
ROA(5y)0.35%
ROE(3y)-18.26%
ROE(5y)-5.7%
ROIC(3y)N/A
ROIC(5y)N/A
SLND Yearly ROA, ROE, ROICSLND Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SLND so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLND Yearly Profit, Operating, Gross MarginsSLND Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

2

2. Health

2.1 Basic Checks

SLND does not have a ROIC to compare to the WACC, probably because it is not profitable.
SLND has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, SLND has a worse debt to assets ratio.
SLND Yearly Shares OutstandingSLND Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
SLND Yearly Total Debt VS Total AssetsSLND Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SLND has an Altman-Z score of 0.75. This is a bad value and indicates that SLND is not financially healthy and even has some risk of bankruptcy.
SLND has a worse Altman-Z score (0.75) than 79.25% of its industry peers.
SLND has a Debt/Equity ratio of 1.79. This is a high value indicating a heavy dependency on external financing.
SLND has a worse Debt to Equity ratio (1.79) than 79.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Altman-Z 0.75
ROIC/WACCN/A
WACC10.38%
SLND Yearly LT Debt VS Equity VS FCFSLND Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.36 indicates that SLND should not have too much problems paying its short term obligations.
SLND has a Current ratio (1.36) which is in line with its industry peers.
A Quick Ratio of 1.36 indicates that SLND should not have too much problems paying its short term obligations.
The Quick ratio of SLND (1.36) is better than 64.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.36
SLND Yearly Current Assets VS Current LiabilitesSLND Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

SLND shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.51%.
The Revenue for SLND has decreased by -23.36% in the past year. This is quite bad
Measured over the past years, SLND shows a decrease in Revenue. The Revenue has been decreasing by -1.32% on average per year.
EPS 1Y (TTM)-48.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.21%
Revenue 1Y (TTM)-23.36%
Revenue growth 3Y-8.49%
Revenue growth 5Y-1.32%
Sales Q2Q%-14.37%

3.2 Future

Based on estimates for the next years, SLND will show a very strong growth in Earnings Per Share. The EPS will grow by 29.68% on average per year.
SLND is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.84% yearly.
EPS Next Y72.18%
EPS Next 2Y38.27%
EPS Next 3Y29.68%
EPS Next 5YN/A
Revenue Next Year0.48%
Revenue Next 2Y0.79%
Revenue Next 3Y5.84%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SLND Yearly Revenue VS EstimatesSLND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
SLND Yearly EPS VS EstimatesSLND Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -1 -2

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SLND. In the last year negative earnings were reported.
Also next year SLND is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLND Price Earnings VS Forward Price EarningsSLND Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLND Per share dataSLND EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as SLND's earnings are expected to grow with 29.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.27%
EPS Next 3Y29.68%

0

5. Dividend

5.1 Amount

No dividends for SLND!.
Industry RankSector Rank
Dividend Yield N/A

SOUTHLAND HOLDINGS INC

NYSEARCA:SLND (9/2/2025, 8:04:00 PM)

After market: 4.02 0 (0%)

4.02

-0.07 (-1.71%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners11.21%
Inst Owner Change-3.51%
Ins Owners76.7%
Ins Owner Change0.33%
Market Cap217.52M
Analysts82.22
Price Target6.12 (52.24%)
Short Float %0.97%
Short Ratio2.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)54.95%
Min EPS beat(2)30.36%
Max EPS beat(2)79.54%
EPS beat(4)3
Avg EPS beat(4)-237.65%
Min EPS beat(4)-1141.83%
Max EPS beat(4)81.33%
EPS beat(8)4
Avg EPS beat(8)-730.93%
EPS beat(12)4
Avg EPS beat(12)-531.64%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.6%
Min Revenue beat(2)-14.09%
Max Revenue beat(2)2.9%
Revenue beat(4)2
Avg Revenue beat(4)-10.2%
Min Revenue beat(4)-44.09%
Max Revenue beat(4)14.49%
Revenue beat(8)5
Avg Revenue beat(8)-3.97%
Revenue beat(12)6
Avg Revenue beat(12)-7.28%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.09%
PT rev (3m)33.33%
EPS NQ rev (1m)-5.17%
EPS NQ rev (3m)-255.56%
EPS NY rev (1m)35.48%
EPS NY rev (3m)35.48%
Revenue NQ rev (1m)-5.56%
Revenue NQ rev (3m)-4.57%
Revenue NY rev (1m)-5.74%
Revenue NY rev (3m)-5.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 1.44
P/tB 1.47
EV/EBITDA N/A
EPS(TTM)-1.5
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS16.55
BVpS2.79
TBVpS2.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.22%
ROE -48.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.66%
ROA(5y)0.35%
ROE(3y)-18.26%
ROE(5y)-5.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.23%
Cap/Sales 0.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.36
Altman-Z 0.75
F-Score2
WACC10.38%
ROIC/WACCN/A
Cap/Depr(3y)25.93%
Cap/Depr(5y)39.23%
Cap/Sales(3y)0.7%
Cap/Sales(5y)1.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.21%
EPS Next Y72.18%
EPS Next 2Y38.27%
EPS Next 3Y29.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-23.36%
Revenue growth 3Y-8.49%
Revenue growth 5Y-1.32%
Sales Q2Q%-14.37%
Revenue Next Year0.48%
Revenue Next 2Y0.79%
Revenue Next 3Y5.84%
Revenue Next 5YN/A
EBIT growth 1Y-110.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year108.14%
EBIT Next 3Y38.84%
EBIT Next 5YN/A
FCF growth 1Y-955.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-387.62%
OCF growth 3YN/A
OCF growth 5YN/A